Nanoviricides (NNVC) Other Accumulated Expenses (2011 - 2023)
Nanoviricides' Other Accumulated Expenses came in at $243,881 for fiscal Q3 2023 (quarter ended Mar 31, 2023), up 231.4% from $73,587 a year earlier but down 34.7% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Other Accumulated Expenses (2011 - 2023) Analysis & Trends
At the end of FY2022 (ended Jun 30, 2022), Nanoviricides' Other Accumulated Expenses was $214,397, up 579.8% from FY2021.
- Other Accumulated Expenses carries a five-year compound annual growth rate of -8.8% (FY2017 to FY2022).
- Going back by fiscal year, Other Accumulated Expenses was $31,539 in FY2021 (-94.4%), $561,580 in FY2020 (-31.8%), $823,783 in FY2019 (+666.5%) and $107,468 in FY2018 (-68.5%).
- The five-year range for quarterly Other Accumulated Expenses is $31,539 (fiscal Q4 2021) to $823,783 (fiscal Q4 2019).
- Year-over-year, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 100.6%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in fiscal Q4 2019 (growth of 666.5%), and the weakest in fiscal Q4 2021 (a decline of 94.4%).
- Business Quant data shows NNVC's Other Accumulated Expenses at $373,424 (Q2 2023), $433,119 (Q1 2023) and $214,397 (Q4 2022) in the three fiscal quarters before Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Nanoviricides | 28.26 Mn | 15.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 243,881.00 |
| Dec 31, 2022 | 373,424.00 |
| Sep 30, 2022 | 433,119.00 |
| Jun 30, 2022 | 214,397.00 |
| Mar 31, 2022 | 73,587.00 |
| Dec 31, 2021 | 166,948.00 |
| Sep 30, 2021 | 705,177.00 |
| Jun 30, 2021 | 31,539.00 |
| Mar 31, 2021 | 583,075.00 |
| Dec 31, 2020 | 128,904.00 |
| Sep 30, 2020 | 437,818.00 |
| Jun 30, 2020 | 561,580.00 |
| Mar 31, 2020 | 578,155.00 |
| Dec 31, 2019 | 737,370.00 |
| Sep 30, 2019 | 714,417.00 |
| Jun 30, 2019 | 823,783.00 |
| Mar 31, 2019 | 730,063.00 |
| Dec 31, 2018 | 800,830.00 |
| Sep 30, 2018 | 718,457.00 |
| Jun 30, 2018 | 107,468.00 |
API Access
Nanoviricides Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();